(March 21, 2016, 12:45 PM EDT) -- NEW ORLEANS — The Louisiana federal judge overseeing the Xarelto multidistrict litigation on March 17 ordered that a confidential discovery document questioning the reliability of the so-called ROCKET AF clinical trial comparing warfarin to Xarelto be delivered to the Food and Drug Administration (In Re: Xarelto [Rivaroxaban] Products Liability Litigation, MDL Docket No. 2592, No. 14-md-2592, E.D. La.)....